Infobird (NASDAQ: IFBD) names Yaqing Wei CEO and chair
Rhea-AI Filing Summary
Infobird Co., Ltd (IFBD) reported a leadership change effective August 24, 2026. Xiangyang Wen resigned as Chief Executive Officer, chairperson of the Board of Directors, and director. On the same date, Yaqing Wei was appointed Chief Executive Officer, Chairperson of the Board, Director, and a member of both the compensation committee and the nomination and governance committee.
The company states that Ms. Wei has prior management and marketing experience at Beijing Aruisite Clinic Co., Ltd and Zhongliang Group China entities, and holds an MBA and a bachelor’s degree from Peking University and California Polytechnic State University. Her employment agreement with Infobird is dated August 24, 2026 and is filed as Exhibit 10.1.
Positive
- None.
Negative
- None.
Key Terms
foreign private issuer, compensation committee, nomination and governance committee
3 terms
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
compensation committee financial
"a Director, a member of compensation committee, and a member"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
nomination and governance committee financial
"and a member of nomination and governance committee of the Company"
FAQ
What leadership changes did Infobird Co., Ltd (IFBD) announce in this Form 6-K?
Infobird announced that Xiangyang Wen resigned as Chief Executive Officer, chairperson of the Board, and director effective August 24, 2026, and that Yaqing Wei was appointed as Chief Executive Officer, Chairperson of the Board, Director, and committee member on the same date.
What roles will Yaqing Wei hold at Infobird Co., Ltd (IFBD)?
Yaqing Wei will serve as Chief Executive Officer, Chairperson of the Board, a Director, a member of the compensation committee, and a member of the nomination and governance committee of Infobird Co., Ltd.
What is the effective date of the CEO transition at Infobird Co., Ltd (IFBD)?
The CEO transition is effective on August 24, 2026. On that date, Xiangyang Wen resigned from his positions and Yaqing Wei was appointed as Chief Executive Officer, Chairperson of the Board, and Director.
What prior experience does new CEO Yaqing Wei have before joining Infobird (IFBD)?
Since May 2025, Yaqing Wei has been the general manager of Beijing Aruisite Clinic Co., Ltd. From February 2016 to May 2025, she worked in marketing leadership roles at Zhongliang Group China’s Alcohol Business Division and China Foods Co., Ltd.
What are the educational qualifications of Infobird (IFBD) CEO Yaqing Wei?
Yaqing Wei holds a Master of Business Administration and a Bachelor’s Degree in International Marketing / Human Resources and Enterprise Management from Peking University and California Polytechnic State University, obtained in 2025 and 2007, respectively.
Is there an employment agreement between Infobird (IFBD) and Yaqing Wei?
Yes. Infobird states that Ms. Wei has entered into an employment agreement with the company dated August 24, 2026, which is filed as Exhibit 10.1 and is incorporated by reference for additional details.
AI-generated analysis. How Rhea-AI works. Not financial advice.
